Dimerix Limited Presentations & Investor Relations material

Dimerix is a public drug discovery company advancing new drug therapies through the clinic for unmet medical needs. We are developing important new combination drug therapies using our proprietary cell-based drug discovery platform. Our lead program, DMX-200, is being developed for chronic kidney disease, and has received FDA Orphan Drug Designation.